Ocugen (OCGN) Short-term Investments (2017 - 2023)

Ocugen (OCGN) reported Short-term Investments of $8.5 million for Q1 2023, down 36.71% quarter-over-quarter from $13.4 million in Q4 2022.

Ocugen (OCGN) Short-term Investments (2017 - 2023) Analysis & Trends

Ocugen has reported Short-term Investments for 3 years, with the latest figure at $8.5 million in Q1 2023.

For the quarter ending Q1 2023, Short-term Investments changed N/A year-over-year to $8.5 million; the trailing twelve-month figure through Mar 2023 stood at $8.5 million (changed N/A YoY), and the FY2022 full-year result was $13.4 million, changed N/A from the prior year.
Short-term Investments for Q1 2023 stood at $8.5 million, down from $13.4 million in the prior quarter.
The five-year high for Short-term Investments was $13.4 million in Q4 2022, with the low at $8.5 million in Q1 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Ocugen	411.07 Mn	411.07 Mn	-

Download Data